Novavax vaccine over 90% effective in U.S. trial

Novavax vaccine over 90% effective in U.S. trial

By Excelsio Media on June 14, 2021 Also in covid-19, United States, vaccine

Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)